BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12449034)

  • 1. [New neoadjuvant approaches using gemcitabine in non-small-cell lung cancer].
    Depierre A; Westeel V; Jacoulet P
    Bull Cancer; 2002 Aug; 89 Spec No():S76-9. PubMed ID: 12449034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combinations of platinum salts and gemcitabine in the treatment of non-small-cell lung cancer].
    Souquet PJ; Gerinière L
    Bull Cancer; 2002 Aug; 89 Spec No():S80-4. PubMed ID: 12449035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platinum-free gemcitabine-based combinations: an alternative to conventional chemotherapy of non-small-cell lung cancers?].
    Pujol JL; Choma D; Jacot W; Quantin X
    Bull Cancer; 2002 Aug; 89 Spec No():S85-90. PubMed ID: 12449036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
    Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine induction chemotherapy in non-small cell lung cancer.
    Depierre A; Westeel V; Jacoulet P
    Semin Oncol; 2002 Jun; 29(3 Suppl 9):55-60. PubMed ID: 12094341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ].
    Gligorov J; André T; Epaud C; Culine S
    Bull Cancer; 2002 Aug; 89 Spec No():S134-44. PubMed ID: 12449045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel (Taxotere) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer. Thoracic Oncology Program.
    Ornstein DL; Nervi AM; Rigas JR
    Ann Oncol; 1999; 10 Suppl 5():S35-40. PubMed ID: 10582137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternative.
    Cappuzzo F; Rocha Lima CM; Sherman CA; Green MR
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):7-14. PubMed ID: 10960939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives and opportunities: Docetaxel in the current and future treatment of non-small cell lung cancer.
    Green MR
    Semin Oncol; 2002 Jun; 29(3 Suppl 12):17-21. PubMed ID: 12170447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine/cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer.
    Scagliotti GV
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):15-9. PubMed ID: 10960940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carboplatin].
    Watanabe H
    Nihon Rinsho; 2002 May; 60 Suppl 5():366-9. PubMed ID: 12101690
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy with docetaxel in non--small cell lung cancer.
    Mattson K
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):33-6. PubMed ID: 11441413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gemcitabine].
    Takeda K
    Nihon Rinsho; 2002 May; 60 Suppl 5():359-65. PubMed ID: 12101689
    [No Abstract]   [Full Text] [Related]  

  • 16. Lung cancer: therapeutic options for stage IV and recurrent NSCLC.
    Calvo AR; Belani CP
    Cancer Treat Res; 2001; 105():189-227. PubMed ID: 11224988
    [No Abstract]   [Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer.
    De Marinis F; Gebbia V; De Petris L
    Ann Oncol; 2005 May; 16 Suppl 4():iv116-122. PubMed ID: 15923411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001].
    Morere JF
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S37-41. PubMed ID: 11924242
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemoradiation in locally advanced non-small cell lung cancer.
    Bonomi P; Shirazi W
    Cancer Treat Res; 2001; 105():171-88. PubMed ID: 11224987
    [No Abstract]   [Full Text] [Related]  

  • 20. [Docetaxel].
    Takigawa N
    Nihon Rinsho; 2002 May; 60 Suppl 5():349-52. PubMed ID: 12101686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.